Skip to main content
Clinical Trials/NCT00378820
NCT00378820UnknownNot Applicable

The Effect of Whey and Casein With and Without Milk Minerals on IGFs in Prepubertal Boys

University of Copenhagen2 sites in 1 country60 target enrollmentStarted: July 1, 2004Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Locations
2
Primary Endpoint
IGF-I

Study Overview

Brief Summary

It is not clear which milk compounds are responsible for the growth stimulation. Through short term intervention studies in prepubertal children, we will test the effects of whey, casein, and milk minerals (especially Ca/P). Outcomes will be IGF-I, IGFBP-3, p-amino acids, oral glucose tolerance test (insulin, glucose, GLP-1 and 2, C-peptide, proinsulin) and markers for bone turn-over in blood and urine (s-osteocalcin, s-bone alkaline phosphatase, urine Dpyr, Ntx) as well as blood pressure.

Detailed Description

Milk has evolved to support high growth velocity in newborns and observational and intervention studies suggest that milk has special growth stimulating properties especially regarding body size, bone mass and gut. We have previously shown that a one week high-dose intervention with milk, but not meat, increased fasting IGF-I and insulin levels in prepubertal boys. It is not clear which milk compounds are responsible for the growth stimulation. Through short term intervention studies in prepubertal children, we will test the effects of whey, casein, and milk minerals (especially Ca/P). Outcomes will be IGF-I, IGFBP-3, p-amino acids, oral glucose tolerance test (insulin, glucose, GLP-1 and 2, C-peptide, proinsulin) and markers for bone turn-over in blood and urine (s-osteocalcin, s-bone alkaline phosphatase, urine Dpyr, Ntx) as well as blood pressure. Exploring the growth stimulating effects of these milk components will improve the understanding of dietary effects on growth and bone metabolism, and will be valuable for the diary industry developing dietary products supporting growth e.g. infant formula, products for clinical nutrition and milk based products for nutritional rehabilitation of malnourished children in developing countries.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Prevention
Masking
Double

Eligibility Criteria

Ages
8 Years to 8 Years (Child)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • habital milk intake:200 - 500 mL/d

Exclusion Criteria

  • chronic illnesses
  • children who suffer from any condition likely to affect their protein metabolism or growth

Outcomes

Primary Outcomes

IGF-I

IGFBP-3

Insulin

Glucose

Secondary Outcomes

  • Blood Pressure
  • Body Composition
  • Adiponectin
  • Osteocalcin
  • BAP
  • Urea Nitrogen
  • Amino Acids
  • Ghrelin
  • C-peptide
  • OGGT
  • Leptin
  • CTX

Investigators

Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials